US BANCORP \DE\ - KITE PHARMA INC ownership

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of KITE PHARMA INC
ValueSharesWeighting
Q3 2017$3,000
-50.0%
16
-65.2%
0.00%
Q2 2017$6,000
+50.0%
46
-24.6%
0.00%
Q1 2017$4,00061
+916.7%
0.00%
Q4 2016$0
-100.0%
6
-98.8%
0.00%
Q2 2016$25,000
+38.9%
502
+25.2%
0.00%
Q1 2016$18,000
-45.5%
401
-26.6%
0.00%
Q2 2015$33,0005460.00%
Other shareholders
KITE PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 2,410,034$433,348,00077.71%
COWEN INC. 4,200,600$755,310,00026.72%
Tyrus Capital S.A.M. 1,314,812$236,416,00018.49%
OMNI PARTNERS LLP 661,711$118,982,00015.19%
FNY Partners Fund LP 379,510$68,239,00011.61%
EQUITEC PROPRIETARY MARKETS, LLC 240,100$43,172,00010.15%
EQUITEC PROPRIETARY MARKETS, LLC 227,500$40,907,0009.62%
GARDNER LEWIS ASSET MANAGEMENT L P 773,817$139,140,0008.89%
Quad Capital Management Advisors LLC 192,537$34,620,0007.10%
Avoro Capital Advisors LLC 496,983$89,363,0006.93%
View complete list of KITE PHARMA INC shareholders